Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an important mediator of tumor immune surveillance. In addition, its potential to kill cancer cells without harming healthy cells led to the development of TRAIL receptor agonists, which however did not show the desired effects in clinical trials. This is caused mainly by apoptosis resistance mechanisms operating in primary cancer cells. Meanwhile, it has been realized that in addition to cell death, TRAIL also induces non-apoptotic pro-inflammatory pathways that may enhance tumor malignancy. Due to its late detection and resistance to current therapeutic options, pancreatic ductal adenocarcinoma (PDAC) is still one of the deadliest types of cancer worldwide. A dysregulated pH microenvironment contributes to PDAC development, in which the cancer cells become highly dependent on to maintain their metabolism. The impact of extracellular pH (pHe) on TRAIL-induced signaling in PDAC cells is poorly understood so far. To close this gap, we analyzed the effects of acidic and alkaline pHe, both in short-term and long-term settings, on apoptotic and non-apoptotic TRAIL-induced signaling. We found that acidic and alkaline pHe differentially impact TRAIL-induced responses, and in addition, the duration of the pHe exposition also represents an important parameter. Thus, adaptation to acidic pHe increases TRAIL sensitivity in two different PDAC cell lines, Colo357 and Panc1, one already TRAIL-sensitive and the other TRAIL-resistant, respectively. However, the latter became highly TRAIL-sensitive only by concomitant inhibition of Bcl-xL. None of these effects was observed under other pHe conditions studied. Both TRAIL-induced non-apoptotic signaling pathways, as well as constitutively expressed anti-apoptotic proteins, were regulated by acidic pHe. Whereas the non-apoptotic pathways were differently affected in Colo357 than in Panc1 cells, the impact on the anti-apoptotic protein levels was similar in both cell lines. In Panc1 cells, adaptation to either acidic or alkaline pHe blocked the activation of the most of TRAIL-induced non-apoptotic pathways. Interestingly, under these conditions, significant downregulation of the plasma membrane levels of TRAIL-R1 and TRAIL-R2 was observed. Summing up, extracellular pH influences PDAC cells’ response to TRAIL with acidic pHe adaptation, showing the ability to strongly increase TRAIL sensitivity and in addition to inhibit TRAIL-induced pro-inflammatory signaling.

Highlights

  • Pancreatic cancer is currently the seventh leading cause of cancer deaths worldwide, despite being relatively infrequent (Bray et al, 2018; Rawla et al, 2019; Christopher et al, 2020)

  • To study the impact of pHe on Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced signaling in pancreatic ductal adenocarcinoma (PDAC) cells, we established Colo357 and Panc1 cell lines adapted for a longer period of time to either of the three pHe conditions: pHe 6.5, pHe 7.6, or pHe 7.4

  • Cells were exposed to TRAIL for 24 h, and cell viability and cell death were studied by live-cell staining with Hoechst, Calcein-AM, and propidium iodide (PI), followed by quantification of the living and dead cells by the NyOne live-cell imager

Read more

Summary

Introduction

Pancreatic cancer is currently the seventh leading cause of cancer deaths worldwide, despite being relatively infrequent (Bray et al, 2018; Rawla et al, 2019; Christopher et al, 2020). Pancreatic ductal adenocarcinoma (PDAC) accounts for more than 90% of all pancreatic cancer cases and occurs in the exocrine pancreas (Christopher et al, 2020; American-Cancer-Society, 2021) Both acini and ductal cells, comprising the exocrine pancreas, have a structured network of ion channels that enables them to regulate pH in the lumen and interstitium, as well as an intracellular pH (pHi) (Novak et al, 2013; Chii et al, 2014; Pallagi et al, 2015). The accumulation of lactate and protons contributes to tumor acidosis through ion channels, while at the same time, pHi is maintained (Chii et al, 2014) This favors tumor progression and therapy resistance (Chii et al, 2014; Vaupel et al, 2019)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call